Cargando…
Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
A 39-year-old male with decreased visual acuity and extensive macular hemorrhage and edema secondary to a hemiretinal vein occlusion was treated with multiple intravitreal injections of bevacizumab 1.25 mg every four to six weeks for over one year. Treatment outcomes were assessed by visual acuity a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206123/ https://www.ncbi.nlm.nih.gov/pubmed/22069354 http://dx.doi.org/10.2147/OPTH.S23698 |